+1 347 708 0418
Immuno-Oncology Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Immuno-Oncology Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Segment by Application
Hospitals
Ambulatory Surgical Center
Others
By Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Monoclonal Antibodies
1.2.4 Cytokine-Based Immunotherapy
1.2.5 Cancer Vaccines
1.2.6 CAR-T Cell Therapy
1.3 Market by Application
1.3.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Treatment Market Perspective (2017-2028)
2.2 Immuno-Oncology Treatment Growth Trends by Region
2.2.1 Immuno-Oncology Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immuno-Oncology Treatment Historic Market Size by Region (2017-2022)
2.2.3 Immuno-Oncology Treatment Forecasted Market Size by Region (2023-2028)
2.3 Immuno-Oncology Treatment Market Dynamics
2.3.1 Immuno-Oncology Treatment Industry Trends
2.3.2 Immuno-Oncology Treatment Market Drivers
2.3.3 Immuno-Oncology Treatment Market Challenges
2.3.4 Immuno-Oncology Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Treatment Players by Revenue
3.1.1 Global Top Immuno-Oncology Treatment Players by Revenue (2017-2022)
3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-Oncology Treatment Revenue
3.4 Global Immuno-Oncology Treatment Market Concentration Ratio
3.4.1 Global Immuno-Oncology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Treatment Revenue in 2021
3.5 Immuno-Oncology Treatment Key Players Head office and Area Served
3.6 Key Players Immuno-Oncology Treatment Product Solution and Service
3.7 Date of Enter into Immuno-Oncology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Treatment Breakdown Data by Type
4.1 Global Immuno-Oncology Treatment Historic Market Size by Type (2017-2022)
4.2 Global Immuno-Oncology Treatment Forecasted Market Size by Type (2023-2028)
5 Immuno-Oncology Treatment Breakdown Data by Application
5.1 Global Immuno-Oncology Treatment Historic Market Size by Application (2017-2022)
5.2 Global Immuno-Oncology Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immuno-Oncology Treatment Market Size (2017-2028)
6.2 North America Immuno-Oncology Treatment Market Size by Type
6.2.1 North America Immuno-Oncology Treatment Market Size by Type (2017-2022)
6.2.2 North America Immuno-Oncology Treatment Market Size by Type (2023-2028)
6.2.3 North America Immuno-Oncology Treatment Market Share by Type (2017-2028)
6.3 North America Immuno-Oncology Treatment Market Size by Application
6.3.1 North America Immuno-Oncology Treatment Market Size by Application (2017-2022)
6.3.2 North America Immuno-Oncology Treatment Market Size by Application (2023-2028)
6.3.3 North America Immuno-Oncology Treatment Market Share by Application (2017-2028)
6.4 North America Immuno-Oncology Treatment Market Size by Country
6.4.1 North America Immuno-Oncology Treatment Market Size by Country (2017-2022)
6.4.2 North America Immuno-Oncology Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Immuno-Oncology Treatment Market Size (2017-2028)
7.2 Europe Immuno-Oncology Treatment Market Size by Type
7.2.1 Europe Immuno-Oncology Treatment Market Size by Type (2017-2022)
7.2.2 Europe Immuno-Oncology Treatment Market Size by Type (2023-2028)
7.2.3 Europe Immuno-Oncology Treatment Market Share by Type (2017-2028)
7.3 Europe Immuno-Oncology Treatment Market Size by Application
7.3.1 Europe Immuno-Oncology Treatment Market Size by Application (2017-2022)
7.3.2 Europe Immuno-Oncology Treatment Market Size by Application (2023-2028)
7.3.3 Europe Immuno-Oncology Treatment Market Share by Application (2017-2028)
7.4 Europe Immuno-Oncology Treatment Market Size by Country
7.4.1 Europe Immuno-Oncology Treatment Market Size by Country (2017-2022)
7.4.2 Europe Immuno-Oncology Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Treatment Market Size (2017-2028)
8.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Type
8.2.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Immuno-Oncology Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Application
8.3.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Immuno-Oncology Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Immuno-Oncology Treatment Market Size by Region
8.4.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Treatment Market Size (2017-2028)
9.2 Latin America Immuno-Oncology Treatment Market Size by Type
9.2.1 Latin America Immuno-Oncology Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Immuno-Oncology Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Immuno-Oncology Treatment Market Share by Type (2017-2028)
9.3 Latin America Immuno-Oncology Treatment Market Size by Application
9.3.1 Latin America Immuno-Oncology Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Immuno-Oncology Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Immuno-Oncology Treatment Market Share by Application (2017-2028)
9.4 Latin America Immuno-Oncology Treatment Market Size by Country
9.4.1 Latin America Immuno-Oncology Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Immuno-Oncology Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Treatment Market Size (2017-2028)
10.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Type
10.2.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Immuno-Oncology Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Application
10.3.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Immuno-Oncology Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Immuno-Oncology Treatment Market Size by Country
10.4.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-Oncology Treatment Introduction
11.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.1.5 Amgen Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-Oncology Treatment Introduction
11.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.2.5 AstraZeneca Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Details
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction
11.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.4.5 Eli-Lilly Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-Oncology Treatment Introduction
11.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.5.5 Roche Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.6.5 GlaxoSmithKline Recent Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Details
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction
11.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.7.5 Janssen Biotech Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-Oncology Treatment Introduction
11.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Oncology Treatment Introduction
11.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.9.5 Novartis Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-Oncology Treatment Introduction
11.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.10.5 Pfizer Recent Developments
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-Oncology Treatment Introduction
11.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.11.5 Sanofi Recent Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Details
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.12.5 Spectrum Pharmaceuticals Recent Developments
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-Oncology Treatment Introduction
11.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.13.5 Takeda Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immuno-Oncology Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Cytokine-Based Immunotherapy
Table 5. Key Players of Cancer Vaccines
Table 6. Key Players of CAR-T Cell Therapy
Table 7. Global Immuno-Oncology Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Immuno-Oncology Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Immuno-Oncology Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Immuno-Oncology Treatment Market Share by Region (2017-2022)
Table 11. Global Immuno-Oncology Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Immuno-Oncology Treatment Market Share by Region (2023-2028)
Table 13. Immuno-Oncology Treatment Market Trends
Table 14. Immuno-Oncology Treatment Market Drivers
Table 15. Immuno-Oncology Treatment Market Challenges
Table 16. Immuno-Oncology Treatment Market Restraints
Table 17. Global Immuno-Oncology Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Immuno-Oncology Treatment Revenue Share by Players (2017-2022)
Table 19. Global Top Immuno-Oncology Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2021)
Table 20. Ranking of Global Top Immuno-Oncology Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immuno-Oncology Treatment Product Solution and Service
Table 24. Date of Enter into Immuno-Oncology Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Immuno-Oncology Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Immuno-Oncology Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Immuno-Oncology Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Immuno-Oncology Treatment Revenue Share by Application (2017-2022)
Table 32. Global Immuno-Oncology Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Immuno-Oncology Treatment Revenue Share by Application (2023-2028)
Table 34. North America Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Immuno-Oncology Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Immuno-Oncology Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Immuno-Oncology Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Immuno-Oncology Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Immuno-Oncology Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Immuno-Oncology Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Immuno-Oncology Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Immuno-Oncology Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Immuno-Oncology Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Immuno-Oncology Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Immuno-Oncology Treatment Product
Table 67. Amgen Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 68. Amgen Recent Developments
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Immuno-Oncology Treatment Product
Table 72. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 73. AstraZeneca Recent Developments
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Immuno-Oncology Treatment Product
Table 77. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Developments
Table 79. Eli-Lilly Company Details
Table 80. Eli-Lilly Business Overview
Table 81. Eli-Lilly Immuno-Oncology Treatment Product
Table 82. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 83. Eli-Lilly Recent Developments
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Immuno-Oncology Treatment Product
Table 87. Roche Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 88. Roche Recent Developments
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Immuno-Oncology Treatment Product
Table 92. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 93. GlaxoSmithKline Recent Developments
Table 94. Janssen Biotech Company Details
Table 95. Janssen Biotech Business Overview
Table 96. Janssen Biotech Immuno-Oncology Treatment Product
Table 97. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 98. Janssen Biotech Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Immuno-Oncology Treatment Product
Table 102. Merck Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 103. Merck Recent Developments
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Immuno-Oncology Treatment Product
Table 107. Novartis Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 108. Novartis Recent Developments
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Immuno-Oncology Treatment Product
Table 112. Pfizer Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 113. Pfizer Recent Developments
Table 114. Sanofi Company Details
Table 115. Sanofi Business Overview
Table 116. Sanofi Immuno-Oncology Treatment Product
Table 117. Sanofi Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 118. Sanofi Recent Developments
Table 119. Spectrum Pharmaceuticals Company Details
Table 120. Spectrum Pharmaceuticals Business Overview
Table 121. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product
Table 122. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 123. Spectrum Pharmaceuticals Recent Developments
Table 124. Takeda Company Details
Table 125. Takeda Business Overview
Table 126. Takeda Immuno-Oncology Treatment Product
Table 127. Takeda Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 128. Takeda Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Treatment Market Share by Type: 2021 VS 2028
Figure 2. Immune Checkpoint Inhibitors Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Cytokine-Based Immunotherapy Features
Figure 5. Cancer Vaccines Features
Figure 6. CAR-T Cell Therapy Features
Figure 7. Global Immuno-Oncology Treatment Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Center Case Studies
Figure 10. Others Case Studies
Figure 11. Immuno-Oncology Treatment Report Years Considered
Figure 12. Global Immuno-Oncology Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Immuno-Oncology Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Immuno-Oncology Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Immuno-Oncology Treatment Market Share by Players in 2021
Figure 16. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Immuno-Oncology Treatment Revenue in 2021
Figure 18. North America Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Immuno-Oncology Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Immuno-Oncology Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Immuno-Oncology Treatment Market Size Share by Region (2017-2028)
Figure 38. China Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Immuno-Oncology Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Immuno-Oncology Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 58. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 60. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 61. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 63. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 65. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 66. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 67. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 68. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 69. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Buy
